Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: DHEA study

This article was originally published in The Tan Sheet

Executive Summary

DHEA study: Double-blind clinical trial to study the effect of 100 mg/day doses of DHEA in Alzheimer's patients is being extended by two months and adding subjects with an additional grant from the sponsor, Neurocrine Biosciences. The study, originally scheduled to last six months, is being conducted by Owen Wolkowitz, MD at the University of California-San Francisco and should provide results by the end of 1997 ("The Tan Sheet" Aug. 12, p. 6)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085991

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel